Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Saved in:
| Title: | Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. |
|---|---|
| Authors: | Gozdecka M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Meduri E; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Mazan M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Tzelepis K; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Dudek M; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Knights AJ; Genomics of Gene Regulation, Wellcome Trust Sanger Institute, Hinxton, UK., Pardo M; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Yu L; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Choudhary JS; Proteomic Mass Spectrometry, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Metzakopian E; Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton, UK., Iyer V; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Yun H; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Park N; Sequencing Research Group, Wellcome Trust Sanger Institute, Cambridge, UK., Varela I; Instituto de Biomedicina y Biotecnología de Cantabria (CSIC-UC-Sodercan), Departamento de Biología Molecular, Universidad de Cantabria, Santander, Spain., Bautista R; New Pipeline Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Collord G; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Dovey O; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Garyfallos DA; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., De Braekeleer E; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Kondo S; Laboratory of Molecular Genetics, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Cooper J; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Göttgens B; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK., Bullinger L; Department of Internal Medicine III, Ulm University Medical Centre, Ulm, Germany.; Medical Department, Division of Hematology, Oncology and Tumour Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany., Northcott PA; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA., Adams D; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Vassiliou GS; Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK. gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. gsv20@sanger.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@sanger.ac.uk., Huntly BJP; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. bjph2@cam.ac.uk. |
| Source: | Nature genetics [Nat Genet] 2022 Jul; Vol. 54 (7), pp. 1062. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
